We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Lower Contrast Agent Dose Possible Using 320-Row CT Angiography

By MedImaging International staff writers
Posted on 20 Oct 2011
An analysis of 180-row computed tomography (CT) angiography studies performed using a 320-detector row CT scanner found that a contrast media protocol based on 60 mL of iopamidol,“had sufficient enhancement in more than 96% of coronary segments.”

“Many centers currently use a higher iodine load comparable or equal to 80 ml of iopamidol,” said Frank Rybicki, MD, from Brigham and Women’s Hospital (Boston, MA, USA), and one of the authors of the study. The study revealed, “this is not necessary, and the extra contrast means unnecessary costs and increased risk of contrast-induced nephropathy [CIN] to the patients.”

The risk of CIN is of distinct concern for these patients because they commonly have a renal insufficiency, which is known major risk factor for CIN, Dr. Rybicki added. “We analyzed larger patients only [those with a body mass index of more than 30] and found that 92% of coronary segments had sufficient enhancement,” said Dr. Rybicki. “These results support the general use of 60 mL of iopamidol for CT angiography done on 320-detector row CT scanners,” he said.

The study was published in the October 2011 issue of the American Journal of Roentgenology.

Related Links:

Brigham and Women’s Hospital



Adjustable Mobile Barrier
M-458
MRI System
nanoScan MRI 3T/7T
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
40/80-Slice CT System
uCT 528

Channels

Nuclear Medicine

view channel
Image: LHSCRI scientist Dr. Glenn Bauman stands in front of the PET scanner (Photo courtesy of LHSCRI)

New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer

Detecting recurrent prostate cancer remains one of the most difficult challenges in oncology, as standard imaging methods such as bone scans and CT scans often fail to accurately locate small or early-stage tumors.... Read more

General/Advanced Imaging

view channel
Image: Concept of the photo-thermoresponsive SCNPs (J F Thümmler et al., Commun Chem (2025). DOI: 10.1038/s42004-025-01518-x)

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents

Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.